Zhejiang Gongdong Medical Technology Co., Ltd. (SHA:605369)

SHA:605369 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	1,160	1,136	1,115	975.08	1,469	1,194
Revenue Growth	4.70%	1.84%	14.37%	-33.61%	22.98%	43.95%
Gross Profit Gross Profit Growth	313.27	305.3	363.12	313.66	574.54	525.42
Operating Income Operating Income Growth	105.5	97.24	154.18	109.49	324.22	336.02
Net Income Net Income Growth	56.09	51.51	171.63	109.13	326.04	310.99
Earnings Per Share EPS Growth	0.25	0.23	0.78	0.49	1.48	1.41
EPS Growth	-63.14%	-70.51%	58.25%	-66.80%	5.05%	11.25%

Revenue by Segment

Chart

Fiscal Year	FY 2025
Period Ending	Dec 31, 2025
Medical Testing Medical Testing Growth	480.52
Blood Collection Blood Collection Growth	279.6
Collection Collection Growth	138.55
Medical Care Medical Care Growth	90.53
Commerce Commerce Growth	43.32
Others Others Growth	42.59
Pharmaceutical Packaging Pharmaceutical Packaging Growth	40.63
Total Total Growth	1,116

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	702.3	625.45	443.66	447.68	753.23	808.42
Total Debt Total Debt Growth	240.5	164.37	51.98	35.48	0.31	0.94
Net Cash (Debt) Net Cash Growth	461.8	461.08	391.68	412.19	752.92	807.49
Net Cash Growth	39.70%	17.72%	-4.98%	-45.25%	-6.76%	-0.72%
Net Cash Per Share Net Cash Per Share Growth	2.10	2.06	1.78	1.86	3.43	3.67

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	284.75	253.96	210.38	185.39	282.75	372.99
Capital Expenditures CapEx Growth	-115.95	-111.6	-109.61	-121.82	-172.18	-275.56
Free Cash Flow Free Cash Flow Growth	168.8	142.35	100.77	63.57	110.57	97.43
Free Cash Flow Growth	189.62%	41.26%	58.53%	-42.51%	13.49%	-27.08%

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	27.01%	26.88%	32.56%	32.17%	39.12%	44.00%
Operating Margin	9.10%	8.56%	13.83%	11.23%	22.07%	28.14%
Pretax Margin	6.29%	5.53%	16.92%	12.23%	25.24%	30.21%
Profit Margin	4.84%	4.54%	15.39%	11.19%	22.20%	26.04%
FCF Margin	14.55%	12.53%	9.04%	6.52%	7.53%	8.16%

Dividends

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 2, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Dividend Per Share Dividend Per Share Growth	0.150	0.150	0.500	0.408	0.153	0.704
Dividend Per Share Growth	-75.58%	-70.00%	22.49%	166.62%	-78.26%	7.33%
Dividend Yield	0.93%	0.81%	2.56%	1.49%	0.30%	1.03%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 2, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	63.31	79.73	25.58	57.61	36.48	51.89
Forward PE	18.82	26.89	17.39	26.55	25.25	45.56
P/FCF Ratio	21.04	28.85	43.56	98.89	107.58	165.62
PS Ratio	3.06	3.62	3.94	6.45	8.10	13.51

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 1, 2026

Data Sources Report a data error